Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-7.31 Cr₹52 Cr₹48 Cr₹37 Cr₹6.13 Cr

What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of BALAXI PHARMACEUTICALS is ₹-7.31 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-7.31 Cr
Mar2024₹52 Cr
Mar2023₹48 Cr
Mar2022₹37 Cr
Mar2021₹6.13 Cr

How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-7.31 Cr
Negative
Mar2024 ₹52 Cr
7.39
Mar2023 ₹48 Cr
29.41
Mar2022 ₹37 Cr
507.51
Mar2021 ₹6.13 Cr -

Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹103.1 Cr -0.6% -18.2% -65.9% Stock Analytics
ADANI ENTERPRISES ₹258,491.0 Cr -5.8% -8.5% 2.9% Stock Analytics
REDINGTON ₹18,215.3 Cr -12.3% -12.8% 10.9% Stock Analytics
HONASA CONSUMER ₹9,338.1 Cr -4.1% 4.7% 38% Stock Analytics
MMTC ₹8,197.5 Cr -7.9% -12.3% 15.4% Stock Analytics
LLOYDS ENTERPRISES ₹7,177.9 Cr -7% -24.8% 18.8% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.6%

-18.2%

-65.9%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses